These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15324602)

  • 41. [Hormone replacement therapy and cognitive function].
    Huang CP; Hong CT; Huang IT
    Acta Neurol Taiwan; 2006 Dec; 15(4):273-7. PubMed ID: 17214093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function?
    Bieber EJ; Cohen DP
    Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?
    Brinton RD
    CNS Drugs; 2004; 18(7):405-22. PubMed ID: 15139797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methodological issues in estrogen treatment trials for Alzheimer's disease.
    Mulnard RA
    Ann N Y Acad Sci; 2005 Jun; 1052():173-81. PubMed ID: 16024760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The epidemiology of estrogen replacement therapy and Alzheimer's disease.
    Henderson VW
    Neurology; 1997 May; 48(5 Suppl 7):S27-35. PubMed ID: 9153164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Estrogens and Alzheimer disease].
    Stähelin HB
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mood, cognition and Alzheimer's disease.
    Compton J; van Amelsvoort T; Murphy D
    Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):357-70. PubMed ID: 12099667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progestins and estrogens and Alzheimer's disease.
    Honjo H; Iwasa K; Kawata M; Fushiki S; Hosoda T; Tatsumi H; Oida N; Mihara M; Hirasugi Y; Yamamoto H; Kikuchi N; Kitawaki J
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):305-8. PubMed ID: 15860274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Women's Health Initiative Memory Study: findings and implications for treatment.
    Craig MC; Maki PM; Murphy DG
    Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
    J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preventing cognitive decline in preclinical Alzheimer's disease.
    Riedel WJ
    Curr Opin Pharmacol; 2014 Feb; 14():18-22. PubMed ID: 24565007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
    Kawas C; Resnick S; Morrison A; Brookmeyer R; Corrada M; Zonderman A; Bacal C; Lingle DD; Metter E
    Neurology; 1997 Jun; 48(6):1517-21. PubMed ID: 9191758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.
    Yaffe K; Sawaya G; Lieberburg I; Grady D
    JAMA; 1998 Mar; 279(9):688-95. PubMed ID: 9496988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oestrogens and Alzheimer's disease.
    Birkhäuser MH; Strnad J; Kämpf C; Bahro M
    Int J Geriatr Psychiatry; 2000 Jul; 15(7):600-9. PubMed ID: 10918340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yang G; Wang Y; Sun J; Zhang K; Liu J
    Curr Top Med Chem; 2016; 16(5):520-8. PubMed ID: 26268332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.